Rexon-Eye® stands out as a groundbreaking, non-invasive solution for various treatments of dry eye syndromes.
QMR Technology for Dry Eye Treatment
The heart of the Rexon-Eye® is the unique and patented Quantum Molecular Resonance (QMR®) Technology. It delivers a mild alternate electrical signal containing a specific mix of frequencies (from 4 MHz to 64 MHz) that has been shown to stimulate the natural regeneration of cells, in addition to having an important anti-inflammatory action.
Clinical Applications
Using high-resolution imaging, Placido-disc technology, infrared illumination, and advanced software analysis, the OS1000 supports accurate diagnosis, treatment planning, and long-term patient follow-up.
Clinical Applications
- Evaporative Dry Eye Disease
- Aqueous-Deficient Dry Eye
- Mixed Dry Eye Disease
- Meibomian Gland Dysfunction (MGD)
- Ocular Surface Disease
- Post-Refractive Surgery Dry Eye
- Digital Eye Strain
Key Features
- Patented Quantum Molecular Resonance (QMR®) Technology
- Non-invasive and non-contact therapy
- Non-thermal treatment
- 20-minute treatment sessions
- Four-session treatment protocol
- Stimulates tissue regeneration
- Reduces inflammation
- Supports meibomian gland function
- Evidence-based technology
